Literature DB >> 28706915

The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?

B C John Cho1.   

Abstract

Entities:  

Year:  2017        PMID： 28706915      PMCID： PMC5497101          DOI： 10.21037/atm.2017.04.13

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.

Authors:  Joakim Folkesson; Helgi Birgisson; Lars Pahlman; Bjorn Cedermark; Bengt Glimelius; Ulf Gunnarsson
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

2.  A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.

Authors:  B C John Cho; Ron Feld; Natasha Leighl; Isabelle Opitz; Masaki Anraku; Ming-Sound Tsao; David M Hwang; Andrew Hope; Marc de Perrot
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

3.  Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Karl Uy; Masaki Anraku; Ming S Tsao; Gail Darling; Thomas K Waddell; Andrew F Pierre; Andrea Bezjak; Shaf Keshavjee; Michael R Johnston
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01       Impact factor: 5.209

4.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  V W Rusch; K Rosenzweig; E Venkatraman; L Leon; A Raben; L Harrison; M S Bains; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

5.  Multimodality therapy for malignant pleural mesothelioma.

Authors:  D J Sugarbaker; J P Garcia
Journal:  Chest       Date:  1997-10       Impact factor: 9.410

6.  Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; Natasha B Leighl; Andrew Hope; Thomas K Waddell; Shaf Keshavjee; B C John Cho
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-19       Impact factor: 5.209

7.  Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; B C John Cho; Andrea Bezjak; Masaki Anraku; Ronald Burkes; Heidi Roberts; Ming S Tsao; Natasha Leighl; Shaf Keshavjee; Michael R Johnston
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

8.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Authors:  Lee M Krug; Harvey I Pass; Valerie W Rusch; Hedy L Kindler; David J Sugarbaker; Kenneth E Rosenzweig; Raja Flores; Joseph S Friedberg; Katherine Pisters; Matthew Monberg; Coleman K Obasaju; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

9.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316

10.  A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle.

Authors:  K R Swanson; R C Rostomily; E C Alvord
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640
  10 in total
  1 in total

1.  Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.

Authors:  Duo Xu; Shun-Qing Liang; Haitang Yang; Ursina Lüthi; Carsten Riether; Sabina Berezowska; Thomas M Marti; Sean R R Hall; Rémy Bruggmann; Gregor J Kocher; Ralph A Schmid; Ren-Wang Peng
Journal:  Br J Cancer       Date:  2018-06-20       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.